Bone metabolic markers in bone metastases
- 1 September 1995
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 121 (9-10), 542-548
- https://doi.org/10.1007/bf01197767
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorptionJournal of Bone and Mineral Research, 1994
- Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.Journal of Clinical Endocrinology & Metabolism, 1994
- Healing flare in skeletal metastases from breast cancer.Radiology, 1994
- Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationClinical Chemistry, 1993
- Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseBritish Journal of Cancer, 1992
- Radioimmunoassay of the carboxyterminal propeptide of human type I procollagenClinical Chemistry, 1990
- Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatographyAnalytical Biochemistry, 1984
- DETECTION OF BREAST CARCINOMA METASTASES IN BONE: RELATIVE MERITS OF X-RAYS AND SKELETAL SCINTIGRAPHYThe Lancet, 1983
- Comparison of bone scintigraphy and radiography in multiple myeloma.Radiology, 1980
- Metastases in carcinoma.Analysis of 1000 autopsied casesCancer, 1950